Spinal Muscular Atrophy Treatment Cost in India
Unlock Exclusive Discount : Your Gateway to Premium Healthcare with Medsurge India Health Value Card.
Unlock Exclusive Discount : Your Gateway to Premium Healthcare with Medsurge India Health Value Card.
Muscle loss and weakness are symptoms of spinal muscular atrophy (SMA). Standing, walking, controlling head motions, and, in certain situations, breathing and swallowing might be challenging for someone with SMA. SMA affects some people from birth, while others develop later in adulthood. Some types have an impact on life expectancy.
According to research, SMA affects one out of every 8,000–10,000 persons in the world.
SMA has no cure, although novel medications like nusinersen (Spinraza) and onasemnogene abeparvovec-xioi (Zolgensma) may help reduce the disease’s progression.
Spinal Muscular Atrophy Treatment cost in India is quite affordable when compared to that of other wealthy nations. The success is partly attributable to the sophisticated medical technology found in Indian hospitals as well as the skill of the surgeons. Aside from these advantages, another crucial factor for Spinal Muscular Atrophy Treatment in India is its appeal around the world is its inexpensive cost without compromising clinical standards.
A genetic condition labeled spinal muscular atrophy (SMA) affects the skeletal muscles, peripheral nervous system, and brain.
The word spinal appears in the disease name because the majority of the nerve cells that govern muscles are found in the spinal cord. SMA is muscular because its primary effect is on muscles, which do not receive signals from these nerve cells. Atrophy is the medical term for getting smaller, which is what generally happens to muscles when they’re not stimulated by nerve cells.
SMA is a motor neuron disease that causes the loss of nerve cells called motor neurons in the spinal cord.
The most common form of SMA (chromosome 5 SMA, also known as SMN-related SMA) has a wide range of onset, symptoms, and progression rates. Types 1 through 4 of chromosome 5-related SMA, which is commonly autosomal recessive, are categorized to account for these variances.
The age at which SMA symptoms appear generally coincides with the severity of motor function impairment: The stronger the influence on motor function, the younger the onset age. Children who show symptoms at birth or early in childhood usually have the lowest degree of functioning (type 1). SMA that develops later in life and has a milder course (types 2 and 3, and type 4 in teenagers or adults) is associated with higher levels of motor function.
The symptoms of Spinal Muscular Atrophy differ based on the type. In general, patients with SMA lose muscle control, movement, and strength as the disease progresses. Muscle loss worsens as you become older. The muscles closest to the spine and neck are the most severely affected by the condition. Some SMA patients never walk, sit, or stand. Others’ capacity to perform these acts deteriorates over time.
SMA patients either lack a portion of the SMN1 gene or have an altered (mutated) gene. SMN protein is produced by a healthy SMN1 gene. This protein is required for motor neurons to survive and function properly.
Motor neurons atrophy and die in people with SMA because they do not produce enough SMN protein. As a result, the brain loses its ability to govern voluntary motions, particularly those involving the head, neck, arms, and legs.
SMN2 genes produce a tiny quantity of SMN protein in people as well. An SMN2 gene can be found in up to eight copies in a single person. Because the extra genes compensate for the missing SMN1 protein, having several copies of the SMN2 gene usually results in less severe SMA symptoms. Rare causes of spinal muscular atrophy encompass mutations in genes other than the SMN gene (non-chromosome 5).
When parents or caregivers observe symptoms of SMA in a child, they frequently seek medical help.
For spinal muscular atrophy treatment in India, a doctor will do a thorough medical examination, as well as a family history and a physical examination. They will examine the muscles for floppy or flaccidity, as well as deep tendon reflexes and tongue muscle twitching.
The following Spinal Muscular Atrophy tests may be used for diagnosis purposes:
EMG can be used to examine the health of muscles and the nerve cells that regulate them, known as motor neurons. The doctor can evaluate the fetus in the womb via amniocentesis or chorionic villus sample.
SMA genetic screening at birth is recommended in several jurisdictions. If the illness is detected early enough, it may be possible to cure it before symptoms arise.
Spinal Muscular Atrophy Treatment Cost in India starts from 4200 USD. Please note that the cost mentioned only covers the treatment itself and does not include accommodation, or any other additional expenses.
| Cities | Starting Price |
| Delhi | USD 4200 |
| Gurgaon | USD 4300 |
| Noida | USD 4200 |
| Mumbai | USD 4400 |
| Hyderabad | USD 4200 |
| Chennai | USD 4300 |
| Kolkata | USD 4200 |
| Bangalore | USD 4200 |
Note: Keep in mind that the aforementioned cost provided is solely for the treatment. The overall cost of the Spinal Muscular Atrophy treatment in India will be determined based on several factors.
Various factors can affect the cost of Spinal Muscular Atrophy treatment in India. Your budget is greatly impacted by numerous elements that fail under pre and post-treatment costs. Below are the various factors that can affect the cost of Spinal Muscular Atrophy treatment in India.
Spinal Muscular Atrophy Treatment Cost in India offers exceptional medical services and facilities to patients who come for treatment in India also their facilities rival those of well-known healthcare centers worldwide. Accommodation, meals, and transportation expenses are also covered.
We at, Medsurge India ensure that patients will receive the most affordable Spinal Muscular Atrophy Treatment Cost in India and with the expertise of highly qualified doctors. Furthermore, a foreign patient can save up to 30-40% of the cost in India when compared to their native countries.
India’s healthcare industry has advanced significantly over the past years, as seen by the notable accomplishments it has made. One of the industries that have contributed the most to revenue and is expanding quickly is healthcare. Both public and private providers support the healthcare industry.
Spinal Muscular Atrophy Treatment in India has improved a lot. Modern medical technology and highly skilled medical personnel are available in India. The World Health Organization (WHO) and the US Food and Drug Administration support medical facilities and services. In addition, India provides less expensive treatment alternatives than the US and the UK without sacrificing the standard of healthcare. About one-fourth, less is spent on therapy in India than it is in the United States.
India has an advantage over other countries in terms of medical tourism because of the following:
SMA does not have a cure. Treatment options are determined by the type of SMA and its symptoms. Physical and occupational therapy, as well as assistive devices such as orthopedic braces, crutches, walkers, and wheelchairs, are beneficial to many persons with SMA.
These therapies could also be beneficial:
Another treatment for Spinal Muscular Atrophy, DMTs can assist persons with some forms of SMA to lower the severity of their symptoms and improve their attitude.
Two medications for SMA have been authorized by the Food and Drug Administration (FDA), with more on the way.
SMA is a genetic disorder that, depending on the form, can affect children or adults.
The severity of the symptoms will influence a person's viewpoint. Because the muscles that assist breathing are weak in infants with severe SMA, respiratory illness is a possibility. In certain instances, this condition is lethal.
Many persons with milder variants of SMA can expect to live as long as someone who does not have the disease, while some may require substantial medical care.
Although SMA cannot be prevented, medication, physical therapy, and other techniques can assist a person in living a full and active life.
New and experimental therapeutic approaches are showing promise for treating, preventing, or even curing SMA as researchers understand more about the disorder.
People seeking to start a family who have a family history of SMA should obtain genetic counseling first.
Hospitals that treat Spinal Muscular Atrophy Treatment in India are renowned for their services in patient care and hospitality. The hospitals that do Spinal Muscular Atrophy Treatment in India have some of India’s top neurologists and pediatric neurologists who are experts in their professions. For an international patient, selecting a good hospital for treatment might be challenging. It is a crucial choice that needs to be made while keeping a number of things in mind, such as:
Medsurge India is a prestigious support system for patients looking for doctors, hospitals, and specialized treatments. We’ll find the most suitable medical options for you. Regarding your medical issues, our team will give you a list of certified, reputable, and trusted doctors and hospitals. Apart from that, we offer a treatment strategy that fits your budget and, we assist patients with obtaining travel authorizations, medical visas, and a multitude of other things.
A: Depending on the severity of the symptoms, children with type 2 or type 3 SMA may live complete lives. People who develop SMA in adulthood (type 4) are more likely to be active and have a normal lifespan.
A: Patients with type I spinal muscular atrophy (SMA) have a life expectancy of fewer than two years on average. Longer survival and a higher survival rate have recently been reported as a result of the introduction of proactive therapy.
A: The prognosis depends on the type of SMA. Without therapy, some kinds of SMA can be fatal. People with SMA may appear stable for long periods of time, but without therapy, no improvement should be expected.
A: The SM1 gene is carried by most people in two copies, one from each parent. SMA usually occurs only when both copies of the gene have changed. There are frequently no symptoms if only one copy contains the alteration. That gene, on the other hand, might be passed down from parent to child.
A: Between the tenth and fourteenth weeks of your pregnancy, you can do this. Ultrasound will be used by your doctor to help remove a little bit of tissue from the placenta. Chorionic villi, which contain fetal DNA, are tiny structures found in the tissue. SMA will be evaluated on this DNA.
Spine Surgeon
Senior Consultant
10+ years
Meitra Hospital, Calicut, Kerala
View Doctor
Spine Surgeon
Consultant
10+ years
Apollo Hospitals, Greams Road, Chennai
View Doctor
Spine Surgeon
Consultant
22
Bombay Hospital & Medical Research Center, Mumbai
View Doctor
By using our site, you agree to our Terms and Conditions, Privacy Policy and Refund Policy. Medsurge India provides reliable healthcare information and treatment options to support informed decision-making. Our content is designed to support and complement the guidance of your treating doctor, helping you feel informed and confident throughout your healthcare journey. We also Accept International Payments.
Copyright © 2025 NSM ONLINE SOLUTIONS PRIVATE LIMITED. All rights reserved.
 (1).png)